72603-263-02 : NDC 2026 Code

72603-263-02 : Lacosamide ( Lacosamide )

Additionally :

You can get information about “72603-263-02” NDC code in 72603-263-02 in HTML format

HTML | 72603-263-02 in TXT (Plain Text) format

TXT | 72603-263-02 in PDF (Portable Document Format)

PDF | 72603-263-02 in XML format

XML formats.

NDC Code : 72603-263-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72603-263-02",
    "PackageDescription": "10 VIAL, GLASS in 1 CARTON (72603-263-02)  / 20 mL in 1 VIAL, GLASS (72603-263-01) ",
    "NDC11Code": "72603-0263-02",
    "ProductNDC": "72603-263",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lacosamide",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lacosamide",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20240715",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216335",
    "LabelerName": "NorthStar RxLLC",
    "SubstanceName": "LACOSAMIDE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
    "DEASchedule": "CV",
    "Status": "Active",
    "LastUpdate": "2024-08-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240715",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}